000 01398 a2200385 4500
005 20250517051154.0
264 0 _c20151106
008 201511s 0 0 rus d
022 _a1997-7298
024 7 _a10.17116/jnevro201511541113-125
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKirnichnaya, K A
245 0 0 _a[Pharmacogenetic-based risk assessment of antipsychotic-induced extrapyramidal symptoms].
_h[electronic resource]
260 _bZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
_c2015
300 _a113-125 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Review
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aBasal Ganglia Diseases
_xchemically induced
650 0 4 _aGenetic Markers
_xgenetics
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aGenetic Testing
650 0 4 _aHumans
650 0 4 _aPharmacogenetics
_xtrends
650 0 4 _aRisk Assessment
700 1 _aSosin, D N
700 1 _aIvanov, M V
700 1 _aMikhaylov, V A
700 1 _aIvashchenko, D V
700 1 _aErshov, E E
700 1 _aTaraskina, A E
700 1 _aNasyrova, R F
700 1 _aKrupitsky, E M
773 0 _tZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
_gvol. 115
_gno. 4
_gp. 113-125
856 4 0 _uhttps://doi.org/10.17116/jnevro201511541113-125
_zAvailable from publisher's website
999 _c25216545
_d25216545